Clinical Trials
Source: CCM
- Score: 7Thyroid and Other Endocrine Cancers, Gynecological Cancers
Endometrium and Metabolism
- Score: 6Gynecological Cancers
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy (MK-2870-005/ENGOT-en23/GOG-3095)
- Ages18 years - 99 years
- GenderFemale only
- Score: 5Gynecological Cancers
A Phase II Evaluation of the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Persistent or Recurrent Endometrial Cancer
- Score: 4Gynecological Cancers
A Phase II Evaluation of Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-drug Conjugate, in Patients With Persistent or Recurrent Endometrial Carcinoma
- Score: 3Gynecological Cancers
A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-Oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma
- Score: 2Heart/Cardiovascular, Mental Health & Behavioral Research, Women's Health
Healthy women and women with Endometriosis volunteers needed
- Ages18 years - 45 years
- GenderFemale only
- Score: 1Women's Health
Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis (PREGnant)
- Ages18 years - 38 years
- GenderFemale only
- Score: 0
Trial of Exercise and Lifestyle (TEAL) Intervention